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The Changing Landscape of
Heart Failure Hospitalizations*
Véronique L. Roger, MD, MPH
Rochester, Minnesota
Heart failure (HF) is a major public health problem. In
the mid-1990s, temporal trends from vital statistics
appeared so alarming that the hypothesis of a new
epidemic of HF was formulated (1). Subsequent studies
that formally investigated the epidemic demonstrated
that the incidence of HF had not changed appreciably in
the past 2 decades, and that survival, although still poor,
had improved (2,3). These data convincingly established
that, as the prevalence of HF increased, an epidemic of
hospitalizations among older patients (4) was unfolding,
causing a major burden on patients, healthcare systems,
and society. The American Heart Association forecasts
an alarming 25% increase in the prevalence of HF, which
will further exacerbate the epidemic (5).
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Heart failure also constitutes a major clinical problem
because it is not a disease but a syndrome, the pathophys-
iology of which remains somewhat elusive. It can present
with preserved or reduced ejection fraction (EF), and the
two entities differ in frequency, presentation, outcomes, and
importantly, management options. The case mix of HF is
changing over time (6), with a growing proportion of cases
presenting with preserved EF, for which there is currently
no specific effective treatment. These persisting clinical
challenges and unfavorable trends will also magnify the
epidemic of hospitalizations.
This context underscores the importance of studies
that evaluate hospitalizations in HF, such as the study by
Blecker et al. (7) published in this issue of the Journal.
This work provides important insights into the determi-
nants of the epidemic of hospitalizations, which are
crucial to design effective prevention strategies. The
investigators used the Nationwide Inpatient Sample
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HL72435).(NIS) to evaluate trends in HF hospitalizations between
2001 and 2009. The total number of hospitalizations
with any mention of HF increased from 2001 to 2009.
Hospitalizations were categorized as either primary or
secondary HF hospitalizations based on the position of
HF in the listing of discharge diagnoses. Primary HF
hospitalizations decreased over time, whereas secondary
HF hospitalizations increased during the same period.
Common primary diagnoses for secondary HF hospital-
izations were pulmonary disease, renal failure, and infec-
tions. The investigators concluded that the burden of all
HF hospitalizations remains substantial. Although pri-
mary HF hospitalizations declined, hospitalizations with
a secondary diagnosis of HF were stable, underscoring
that strategies to reduce the burden of hospitalizations
among HF patients should target both cardiac disease
and noncardiac conditions.
A number of methodological points should be consid-
ered to interpret the data. The NIS sample is part of the
Healthcare Cost and Utilization Project, supported by
the Agency for Health Care Policy and Research. Be-
cause the unit of analysis was hospitalizations, not
individual patients, 1 patient might have contributed to
multiple hospitalizations. Diagnostic codes and their
respective order on the dismissal diagnosis list were used
to ascertain HF and comorbidities, and to categorize
events as primary versus secondary HF. Thus, temporal
shifts in coding practices could have confounded the
reported temporal trends. No information on EF was
available; thus, the role of the type of HF on the observed
trends, which is an important issue, could not be ad-
dressed by this report. These data, therefore, should be
considered as hypothesis-generating rather than hypothesis-
testing. Generating questions and hypotheses is, however,
critically important to help advance knowledge. Hence,
these limitations notwithstanding, the investigators should
be commended for their comprehensive evaluation of the
contemporary burden of hospitalizations in HF.
The findings reported by Blecker et al. (7) in this issue
of the Journal, are congruent with other reports from
other data sources. Data from the National Hospital
Discharge Survey between 1979 and 2004 indicated that
hospitalizations with any mention of HF tripled between
1979 and 2004, whereas the proportion of hospitaliza-
tions with respiratory diseases and noncardiovascular,
nonrespiratory diseases as the first-listed diagnoses in-
creased (8). Among Medicare beneficiaries hospitalized
between 1998 and 2008 with a principal diagnosis code
for HF, HF hospitalizations declined by almost 30%,
underscoring that hospitalizations attributed chiefly to
HF were declining (9). These 2 reports, like the Blecker
et al. study, relied on diagnostic codes with events rather
than the patients as the unit of analysis. Using a cohort
design, a community study within a geographically de-
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March 26, 2013:1268–70 Hospitalizations and Heart Failurefined population of patients with incident HF in Olmsted
County, Minnesota, indicated that hospitalizations
among patients with HF were less frequently directly
related to HF (10) or even to cardiovascular disease than
to other comorbid conditions. Hence, there is a conver-
gence of data indicating that hospitalizations for HF does
not equate to hospitalizations because of HF. These data
are particularly important because they highlight a fun-
damental dissonance between epidemiological data and
guidelines and policies. Current standards to manage HF
rely on disease-centric clinical guidelines, applied within
provider-centric systems of care and evaluated by perfor-
mance measures focusing on processes rather than out-
comes. This approach ignores the epidemiology and the
complexity of the HF syndrome, which occurs with other
chronic diseases in an elderly population, as the afore-
mentioned studies illustrated (7–10).
Hence, it is perhaps not unexpected that interventions
to prevent readmissions in HF have shown divergent
effectiveness on HF-related and all-cause hospitalizations
(11). These interventions have been reported in several
meta-analyses, reflecting large numbers of studies and
patients (12–18). Although they differ, their common
feature is a disease-centric approach targeting the cardio-
vascular system and largely ignoring multimorbidity.
These interventions have been effective chiefly on HF-
related hospitalizations among patients who present with
HF and reduced EF, with a more modest effect on
hospitalizations related to other causes (11), which,
however, constitute most hospitalizations in HF (7–10).
Thus, disease-centric interventions cannot be expected to
have a far-reaching effect on the population burden of
hospitalizations in HF; new approaches are needed to
contain the hospitalization epidemic among all patients
with HF. The Hospital Readmissions Reduction Pro-
gram of the Patient Protection and Affordable Care Act
plans to adjust downward Medicare payment beginning
in 2013 for hospitals with “excess” 30-day readmissions
rates. As readmissions become a formal quality indicator,
the need to inform policy by a clinical understanding of
the taxonomy, causes, and distribution of causes of
readmissions is becoming urgent (19). The report by
Blecker et al. (7) is helpful in this regard.
To be effective, new approaches must recognize that the
most common chronic condition experienced by adults is
ultimorbidity” (20), a consideration of crucial relevance to
F (21). To improve population health, treatment guide-
ines and performance measures must be designed while
actoring how diseases present and evolve in clinically
elevant communities (22). This is essential to avoid unat-
ended and potentially negative consequences of relying on
isease-centric approaches (23).
Specifically for HF, as the current report by Blecker et
l. (7) indicates, it is time to recognize that to effectively
revent readmissions in these patients in whom HF
oexists with multiple other diseases, we need a greaterfocus on comorbidities across the spectrum of the HF
syndrome.
Reprint requests and correspondence: Dr. Véronique L. Roger,
Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
E-mail: roger.veronique@mayo.edu.
REFERENCES
1. Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of
the millennium: triumphs, concerns, and opportunities. N Engl J Med
1997;337:1360–9.
2. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure
incidence and survival in a community-based population. JAMA
2004;292:344–50.
3. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the
incidence of and survival with heart failure. N Engl J Med 2002;347:
1397–402.
4. Barker WH, Mullooly JP, Getchell W. Changing incidence and
survival for heart failure in a well-defined older population, 1970-1974
and 1990-1994. Circulation 2006;113:799–805.
5. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke
statistics–2012 update: a report from the American Heart Association.
Circulation 2012;125:e2–e220.
6. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield
MM. Trends in prevalence and outcome of heart failure with preserved
ejection fraction. N Engl J Med 2006;355:251–9.
7. Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure–
associated hospitalizations in the United States. J Am Coll Cardiol
2013;61:1259–67.
8. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related
hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol
2008;52:428–34.
9. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional
trends in heart failure hospitalization and mortality rates for Medicare
beneficiaries, 1998–2008. JAMA 2011;306:1669–78.
10. Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after
heart failure diagnosis: a community perspective. J Am Coll Cardiol
2009;54:1695–702.
11. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Which
components of heart failure programmes are effective? A systematic
review and meta-analysis of the outcomes of structured telephone
support or telemonitoring as the primary component of chronic heart
failure management in 8323 patients: Abridged Cochrane Review. Eur
J Heart Fail 2011;13:1028–40.
12. McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic
review of randomized trials of disease management programs in heart
failure. Am J Med 2001;110:378–84.
13. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F.
The effectiveness of disease management programmes in reducing
hospital re-admission in older patients with heart failure: a systematic
review and meta-analysis of published reports. Eur Heart J 2004;25:
1570–95.
14. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary
strategies for the management of heart failure patients at high risk for
admission: a systematic review of randomized trials. J Am Coll Cardiol
2004;44:810–9.
15. Gwadry-Sridhar FH, Flintoft V, Lee DS, Lee H, Guyatt GH. A
systematic review and meta-analysis of studies comparing readmission
rates and mortality rates in patients with heart failure. Arch Intern
Med 2004;164:2315–20.
16. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin
HR. Comprehensive discharge planning with postdischarge support
for older patients with congestive heart failure: a meta-analysis. JAMA
2004;291:1358–67.
17. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Tel-
emonitoring or structured telephone support programmes for patients
with chronic heart failure: systematic review and meta-analysis. BMJ
2007;334:942.
1270 Roger JACC Vol. 61, No. 12, 2013
Hospitalizations and Heart Failure March 26, 2013:1268–7018. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A
meta-analysis of remote monitoring of heart failure patients. J Am Coll
Cardiol 2009;54:1683–94.
19. Joynt KE, Jha AK. Thirty-day readmissions–truth and consequences.
N Engl J Med 2012;366:1366–9.
20. Tinetti M, Fried T, Boyd C. Designing health care for the most common
chronic condition—multimorbidity. JAMA 2012;307:2493–4.
21. Wong CY, Chaudhry SI, Desai MM, Krumholz HM. Trends in
comorbidity, disability, and polypharmacy in heart failure. Am J Med
2011;124:136–43.22. Tinetti ME, Bogardus ST Jr., Agostini JV. Potential pitfalls of
disease-specific guidelines for patients with multiple conditions.
N Engl J Med 2004;351:2870–4.
23. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical
practice guidelines and quality of care for older patients with multiple
comorbid diseases: implications for pay for performance. JAMA
2005;294:716–24.Key Words: comorbidity y heart failure y hospitalizations.
